Kadans Science Partner, the life sciences real estate specialist owned by AXA IM, has increased its portfolio with two assets in London’s King's Cross.
Premium subscriber content – please log in to read more or take a free trial.
Proud to serve European real estate markets since 2006
Axa’s Kadans has ‘unwavering confidence’ in London’s life science sector as it reveals two more assets
- In Alternatives Watch
- 20:22, 27 July 2022
Events
Latest news
-
-
K-Fastigheter closes €94m apartment sale in Denmark
- Living Watch
- 26-Apr-2024 11:32
-
Castellum sells €90m portfolio to fund new projects
- Office Watch
- 26-Apr-2024 11:24
-
Osae Partners picks up €107m Paris asset from Deka
- Office Watch
- 26-Apr-2024 11:10
-
Derwent sells €90m London asset to Titan
- Office Watch
- 26-Apr-2024 11:03
-
-
Bank Intesa offloads €500m of Italian offices to Coima fund
- Office Watch
- 26-Apr-2024 10:18
-
Hurlington secures planning for €175m PBSA-led scheme in London
- Living Watch
- 26-Apr-2024 10:09
-
-
Kryalos and Crossbay add Italian assets to portfolio
- Logistics Watch
- 25-Apr-2024 14:48
-
-
-
JTRE kicks off German business with Berlin project
- Living Watch
- 25-Apr-2024 10:29
-
MPC Capital selects new CEO
- People Watch
- 25-Apr-2024 10:14
-
RQI Immobilien buys seed investment for €100m vehicle
- Living Watch
- 25-Apr-2024 09:56
-
-
-
Listed ground rents company sees valuation downgrade
- Living Watch
- 24-Apr-2024 16:31
-
Will capital raising recover in 2024?
- Capital Watch
- 24-Apr-2024 13:54
-
Best read stories
-
CDC Investissement Immobilier and Covivio link up on German residential
- 23-Apr-2024
CDC Investissement Immobilier, the real estate asset management subsidiary of French financial institution Caisse des Dépôts, has inked a strategic partnership with Covivio in Germany.
-
-
- 23-Apr-2024
Commerz Real acquires solar projects in Sweden
-
-
